KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Amortization of Deferred Charges (2016 - 2020)

Historic Amortization of Deferred Charges for Exact Sciences (EXAS) over the last 12 years, with Q4 2020 value amounting to -$49.9 million.

  • Exact Sciences' Amortization of Deferred Charges fell 7900.46% to -$49.9 million in Q4 2020 from the same period last year, while for Dec 2020 it was -$33.1 million, marking a year-over-year decrease of 8911.17%. This contributed to the annual value of $7.1 million for FY2022, which is 664.37% up from last year.
  • As of Q4 2020, Exact Sciences' Amortization of Deferred Charges stood at -$49.9 million, which was down 7900.46% from $1.1 million recorded in Q3 2020.
  • Over the past 5 years, Exact Sciences' Amortization of Deferred Charges peaked at $14.6 million during Q1 2020, and registered a low of -$49.9 million during Q4 2020.
  • Its 5-year average for Amortization of Deferred Charges is -$1.1 million, with a median of $208000.0 in 2016.
  • In the last 5 years, Exact Sciences' Amortization of Deferred Charges plummeted by 43333.33% in 2017 and then soared by 8534166.67% in 2018.
  • Over the past 5 years, Exact Sciences' Amortization of Deferred Charges (Quarter) stood at $12000.0 in 2016, then crashed by 433.33% to -$40000.0 in 2017, then soared by 25427.5% to $10.1 million in 2018, then plummeted by 375.26% to -$27.9 million in 2019, then tumbled by 79.0% to -$49.9 million in 2020.
  • Its last three reported values are -$49.9 million in Q4 2020, $1.1 million for Q3 2020, and $1.1 million during Q2 2020.